Form 4: Janux Therapeutics Director Alana B. McNulty Receives Stock Options and Restricted Stock Units

Director Alana B. McNulty receives stock options and restricted stock units in Janux Therapeutics, Inc.

Summary

• On June 26, 2024, Alana B. McNulty, a director of Janux Therapeutics, Inc., was granted 2,500 restricted stock units (RSUs) and an option to purchase 8,350 shares of common stock.
• The RSUs will vest on the earlier of June 26, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continuous service.
• The stock options, with an exercise price of $39.80, will vest in equal monthly installments over 12 months following June 26, 2024, but will be fully vested by the date of the next annual meeting of the Issuer's stockholders, subject to continuous service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting schedules incentivize continued service and contribution to the company's success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.

Industry Context

This is a standard practice for compensating and incentivizing board members in publicly traded companies, particularly in the biotech industry.

Comparison to Industry Standards

• Stock option grants and RSU awards are common compensation tools for directors in biotech companies.
• The vesting schedules are typical, designed to retain talent and align interests with long-term company performance.
• Comparable companies like Amgen, Gilead, and Biogen also utilize similar equity-based compensation plans for their board members.

Stakeholder Impact

• The grant of equity to a director can positively impact shareholders by aligning interests and incentivizing value creation.
• Employees may view this as a positive sign of commitment from the board.

Key Dates